1-3 of 3
Bernhard Frankenberger
Close
Sort by
Journal Articles

TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo

Stefani Spranger, Irmela Jeremias, Susanne Wilde, Matthias Leisegang, Lilian Stärck, Barbara Mosetter, Wolfgang Uckert, Mirjam H. M. Heemskerk, Dolores J. Schendel, Bernhard Frankenberger
Journal: Blood
Blood (2012) 119 (15): 3440–3449.
https://doi.org/10.1182/blood-2011-06-357939
Published: 2012
Includes: Supplemental data
Journal Articles

Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity

Susanne Wilde, Daniel Sommermeyer, Bernhard Frankenberger, Matthias Schiemann, Slavoljub Milosevic, Stefani Spranger, Heike Pohla, Wolfgang Uckert, Dirk H. Busch, Dolores J. Schendel
Journal: Blood
Blood (2009) 114 (10): 2131–2139.
https://doi.org/10.1182/blood-2009-03-209387
Published: 2009
Journal Articles

Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies

Ingrid G. Schuster, Dirk H. Busch, Elfriede Eppinger, Elisabeth Kremmer, Slavoljub Milosevic, Christine Hennard, Christina Kuttler, Joachim W. Ellwart, Bernhard Frankenberger, Elfriede Nößner, Christoph Salat, Christian Bogner, Arndt Borkhardt, Hans-Jochem Kolb, Angela M. Krackhardt
Journal: Blood
Blood (2007) 110 (8): 2931–2939.
https://doi.org/10.1182/blood-2006-11-058750
Published: 2007
Includes: Supplemental data